Linezolid Granule, For Suspension
Product Images NDC 60687-754

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Linezolid (NDC 60687-754). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by American Health Packaging, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

100 mg/5 mL Linezolid For Oral Suspension Bottle (100 mg Per 5 mL Linezolid Os Bottle)

Label for Linezolid oral suspension granules, 100 mg/5 mL, in a 150 mL bottle when constituted. It includes storage instructions, mixing directions, manufacturer Annora Pharma Pvt. Ltd., and distributor American Health Packaging. The label cautions that it is Rx only and not for injection.*

FDA Label Image

100 mg Per 5 mL Linezolid For Oral Suspension Carton (100 mg Per 5 mL Linezolid Os Carton)

Linezolid 100 mg/5 mL oral suspension granules packaging label by American Health Packaging. The label shows a 150 mL (when constituted) bottle containing granules for suspension with 100 mg Linezolid USP per 5 mL dose. Includes storage instructions at 25°C, usage warnings, mixing directions, manufacturer details (Amora Pharma Pvt. Ltd., India), and distributor information (American Health Packaging, Ohio).*

FDA Label Image

Structural Formula (Structure)

Chemical structure of Linezolid, a human prescription drug active ingredient shown as a detailed molecular diagram with rings, functional groups, and bonds.*

FDA Label Image

Figure 1. Plasma Concentrations Of Linezolid In Adults At Steady-state Following Oral Dosing Every 12 Hours (mean ± Standard Deviation, N=16) (Image 01)

A line graph showing plasma concentration of linezolid over time after a 600 mg oral dose every 12 hours. The x-axis represents time in hours post-dose, and the y-axis shows linezolid plasma concentration in micrograms per milliliter, indicating peak concentration shortly after dosing followed by a gradual decline over 12 hours.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.